ARCHIVES

Shubick Committee Support New System for NCU Review, Action On Chemicals

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

Vermont Cancer Center’s NCI Core Grant Renewed.

May 11, 2001

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011